The supply chain story behind Zenas BioPharma ZBIO earnings Q4 2025 Below Expectations Xtant XTNT Stock Risks and Growth Potential Q4 2025 Earnings Beat Estimates Onconetix ONCO Sector Trends Onconetix Inc Posts 815B Revenue 025 EPS No Prior Estimates